Saar Biotech
Saar Biotech is a privately held Indian pharmaceutical contract manufacturer operating an 80,000+ sq ft WHO-GMP-certified facility in Baddi with four specialized production units, serving 2,100+ pharma brands, FMCG companies, and PCD franchise owners across oral liquids, topicals, sterile, and ayurvedic formulations.
- Company typePrivate
- Founded2005
- HeadquartersChandigarh, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Saar Biotech does
Saar Biotech Private Limited is a privately held pharmaceutical contract manufacturer headquartered in Chandigarh, India, operating an 80,000+ sq ft manufacturing campus in Baddi, Himachal Pradesh across four specialized production units: Unit I (oral liquids and topicals), Unit II/DM Pharma (tablets, capsules, and cosmetics), Unit III (sterile injectables and aseptic formulations), and Unit IV/Vinca Life Sciences (Ayurvedic formulations). The company has been operating under WHO-GMP, ISO 9001:2015, GLP, Schedule M, and FSSAI certifications since 2005, with documented production capacity of 50,000 liquid units per day and a portfolio of 240+ DCGI-approved formulations spanning 12 therapeutic categories and 10 dosage form categories.
The core technology stack centers on pharmaceutical formulation chemistry rather than software or AI: proprietary nano-emulsion/micellization for fat-soluble vitamins (notably Cholecalciferol/Vitamin D3), nitrogen sparging for oxygen-sensitive API stabilization, HPLC and UV-based GLP analytical testing on Agilent and Shimadzu instrumentation, and segregated Beta-Lactam/Non-Beta-Lactam manufacturing lines. The company serves three primary customer segments: pharmaceutical brands and marketing companies outsourcing production (named clients include Novartis, Sanofi Aventis, MSD, P&G, Marico, Nicholas Piramal, Medley, Provimi), PCD franchise owners acquiring distribution rights across Indian territories, and wellness/FMCG brands requiring private-label manufacturing.
Saar Biotech generates revenue through per-batch contract manufacturing fees, private-label production contracts, and bundled regulatory/documentation services (DCGI licensing, COA issuance, batch documentation), with all pricing provided on a custom quote basis anchored to MOQs of 5,000–10,000 units per SKU. Distribution is exclusively B2B via direct sales outreach, WhatsApp/email enquiry channels, IndiaMART marketplace listing, and content marketing, with no retail or consumer-facing channels. End markets span domestic India plus export orders to the Middle East, CIS, and Southeast Asia, with a documented 30–45 working day turnaround from artwork approval to first batch dispatch.
Saar Biotech firmographics
Firmographics- Name
- Saar Biotech
- Legal name
- SAAR BIOTECH PRIVATE LIMITED
- Website
- https://saarbiotech.in
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Saar Biotech is a privately held Indian pharmaceutical contract manufacturer operating an 80,000+ sq ft WHO-GMP-certified facility in Baddi with four specialized production units, serving 2,100+ pharma brands, FMCG companies, and PCD franchise owners across oral liquids, topicals, sterile, and ayurvedic formulations.
- Ownership category
- akta.pro rank
Saar Biotech industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industries
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Saar Biotech is headquartered
LocationHeadquarters
- HQ city
- Chandigarh
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Saar Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Third-Party/Contract Manufacturing: Saar Biotech generates revenue by manufacturing pharmaceutical formulations on behalf of B2B clients — pharmaceutical brands, marketing companies, PCD franchise owners, and wellness brands. Revenue is earned through production fees per batch, with pricing based on MOQs, formulation complexity, pack format, and order volume. The company provides end-to-end manufacturing including formulation, packaging, batch documentation, and COA issuance. Turnaround from artwork approval to first dispatch is 30-45 working days.
- Private Label Manufacturing: The company manufactures private-label pharmaceutical and nutraceutical products for brands, providing formulation, packaging design, regulatory documentation support, and batch production under WHO-GMP standards. Clients can launch products under their own brand names using Saar Biotech's DCGI-approved formulations.
- Regulatory & Documentation Services: Saar Biotech provides DCGI licensing support, state permissions, COA (Certificate of Analysis) issuance, and batch documentation — integral services bundled with manufacturing contracts to facilitate market entry for brand owners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Custom quote per batch — MOQ-based pricing |
| One time/ perpetual license | Pay-as-you-go | Private Label Manufacturing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Saar Biotech product offering
Product offeringCore offering
Saar Biotech operates as a WHO-GMP certified pharmaceutical contract manufacturer providing third-party manufacturing of oral liquids, suspensions, syrups, topicals, nasal sprays, and oral drops for pharmaceutical brands, PCD franchise owners, and wellness/FMCG brands. The company runs 4 dedicated production units in Baddi, Himachal Pradesh offering end-to-end manufacturing including formulation, packaging, batch documentation, COA issuance, and DCGI regulatory support with a 30-45 day standard turnaround from artwork approval to first dispatch.
Product overview
Saar Biotech operates as a WHO-GMP certified pharmaceutical contract manufacturer with four specialized manufacturing units in Baddi, Himachal Pradesh. The company offers third-party manufacturing services across five core product categories: Oral Suspensions (including Azithromycin, Paracetamol, Ofloxacin combinations), Pharmaceutical Syrups (cough, allergy, and respiratory formulations), Topical Gels & Ointments (Diclofenac-based analgesics), Nasal & Oral Sprays (saline and medicated sprays), and Oral Drops (Vitamin D3 pediatric formulations). The portfolio spans over 240 DCGI-approved formulations across 12 therapeutic categories. The company manages an internal InfinityPlus workflow platform for B2B partner coordination. Manufacturing is delivered through specialized units: Unit I (Oral Liquids & Topicals), Unit II/DM Pharma (Tablets, Capsules & Cosmetics), Unit III (Sterile/Injections), and Unit IV/Vinca Life Sciences (Ayurvedic). Lead time is 30-45 days from artwork approval to first batch dispatch.
Differentiator
Problem solved
Functional benefit
Brands
- DM Pharma: Specialized unit for Tablets, Capsules & Cosmetics manufacturing
- Vinca Life Sciences
Products and services
- Third-Party Pharmaceutical Manufacturing
- Pharmaceutical Syrups Manufacturing
- Oral Suspensions Manufacturing
- Topical Gels & Ointments Manufacturing
- Nasal & Oral Sprays Manufacturing
- Oral Drops Manufacturing
- Private Label Pharmaceutical & Nutraceutical Manufacturing
Companies that use Saar Biotech
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
Saar Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Saar Biotech partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- Medley PharmaceuticalscoreMedley Pharmaceuticals outsources high-compliance pediatric syrup lines and multivitamin liquids to Saar Biotech for high-volume domestic distribution. This is a long-term third-party manufacturing partnership leveraging Saar Biotech's WHO-GMP certified Baddi facility and automated liquid filling lines.
- MHS PharmaceuticalscoreMHS Pharmaceuticals entrusts Saar Biotech with large-scale third-party manufacturing orders for anti-inflammatory suspensions and specialized pediatric dosages, relying on Saar Biotech's GLP-certified testing protocols and formulation expertise.
- MaricocoreMarico outsources production of advanced topical ointments and personal care formulations to Saar Biotech, manufactured under strict stability conditions in the Baddi facility's dedicated topical production unit.
- MSD PharmaceuticalscoreMSD Pharmaceuticals leverages Saar Biotech's GLP-compliant analytical labs and sterile production lines for specialized oral liquid contract manufacturing, utilizing Saar Biotech's advanced HPLC/UV instrumentation for quality assurance.
- Nicholas PiramalcoreNicholas Piramal places high-volume third-party manufacturing orders with Saar Biotech for DCGI-approved wellness liquids and therapeutic compositions, benefiting from Saar Biotech's 240+ pre-approved formulation portfolio.
- Sanofi AventiscoreSanofi Aventis utilizes Saar Biotech's WHO-GMP certified infrastructure to fulfill contract manufacturing requirements for precise oral liquids and clinical formulations, ensuring batch integrity and regulatory compliance.
- NovartiscoreNovartis collaborates with Saar Biotech's advanced Baddi facility for precision manufacturing of high-compliance therapeutic suspensions and targeted delivery formats, leveraging the facility's segregated production lines and GLP-certified QC.
Scale indicators9 records
Recent moves5 records
Expansion highlights5 records
Saar Biotech competitors and assessment
Company assessmentDirect peers
- Bioplus Life Sciences: Bioplus Life Sciences is a Baddi-based Indian pharmaceutical contract manufacturer offering WHO-GMP certified oral liquids, suspensions, tablets, and injectables. Direct geographic and operational peer to Saar Biotech, competing in the same northern India CDMO cluster.
- Synokem Pharmaceuticals: Synokem is a Delhi-NCR based Indian CDMO providing third-party manufacturing across multiple dosage forms including liquids, topicals, and oral solids. Direct peer to Saar in target customer (PCD franchise, pharma marketing companies), B2B sales-led GTM, and WHO-GMP certified multi-unit operations.
- Akums Drugs & Pharmaceuticals: Akums is India's largest pharmaceutical contract manufacturer offering WHO-GMP formulation services across oral solids, liquids, topicals, and sterile injectables. Directly comparable to Saar in B2B CDMO model, multi-format dosage production, and Indian pharma customer base — Akums operates at materially larger scale with 10+ manufacturing facilities.
- Zim Laboratories: Zim Labs is an Indian pharmaceutical CDMO specializing in oral solid, liquid, and topical formulations with focus on differentiated drug delivery and pre-approved formulations. Comparable to Saar in third-party manufacturing model and pre-approved formulation library, with stronger export presence.
- Tirupati Medicare: Tirupati Medicare is an Indian pharmaceutical contract manufacturer offering third-party manufacturing of oral liquids, suspensions, tablets, capsules, and injectables. Direct peer to Saar with similar B2B GTM, pre-approved formulation library, and WHO-GMP certification in northern India.
- Centaur Pharmaceuticals: Centaur Pharmaceuticals is an Indian pharma manufacturer with WHO-GMP facilities producing generics, formulations, and APIs. Comparable to Saar in Indian manufacturing scale, multi-dosage form production, and B2B pharmaceutical supply for domestic and export markets.
Broad incumbents
- Cipla: Cipla is one of India's largest generic pharmaceutical manufacturers with extensive WHO-GMP manufacturing infrastructure and a broad portfolio across dosage forms and therapeutic areas. While primarily a brand-led company, Cipla operates contract manufacturing services and represents the broader incumbent that Indian CDMOs like Saar supply and compete against.
- Mankind Pharma: Mankind Pharma is a top-3 Indian pharmaceutical company with extensive in-house manufacturing and historically significant third-party outsourcing from CDMOs like Saar. As a broad incumbent in Indian generics, Mankind is both a customer and a benchmark competitor for scale and formulation breadth.
- Alkem Laboratories: Alkem Laboratories is a large Indian multinational pharmaceutical company with WHO-GMP manufacturing across formulations and APIs. Broad incumbent in the same Indian pharma manufacturing ecosystem, with both in-house production and outsourced volumes from CDMOs.
Emerging players
- Morepen Laboratories: Morepen Laboratories is an Indian pharma and API manufacturer with WHO-GMP facilities offering contract manufacturing for oral solids, liquids, and active pharmaceutical ingredients. Comparable to Saar in B2B CDMO services, though more API-focused and with different therapeutic category emphasis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Saar Biotech social profiles
Digital presenceSaar Biotech compliance and trust
Trust signalCompliance5 records
Saar Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Saar Biotech leadership team
Management profileNumber of profiles
Profiles2 records
Saar Biotech subsidiaries and ownership
Company hierarchySubsidiaries4 records
Saar Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Saar Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Saar Biotech
What does Saar Biotech do?
Saar Biotech operates as a WHO-GMP certified pharmaceutical contract manufacturer providing third-party manufacturing of oral liquids, suspensions, syrups, topicals, nasal sprays, and oral drops for pharmaceutical brands, PCD franchise owners, and wellness/FMCG brands. The company runs 4 dedicated production units in Baddi, Himachal Pradesh offering end-to-end manufacturing including formulation, packaging, batch documentation, COA issuance, and DCGI regulatory support with a 30-45 day standard turnaround from artwork approval to first dispatch.
Is Saar Biotech a public or private company?
Saar Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Saar Biotech founded?
Saar Biotech was founded in 2005. It employs 11 to 50 people.
Where is Saar Biotech based?
Saar Biotech is headquartered in Chandigarh, India, in the Asia region.
How does Saar Biotech make money?
Three revenue lines are on record. Third-Party/Contract Manufacturing is the primary driver. The others are private Label Manufacturing and regulatory & Documentation Services.
Who are Saar Biotech's main competitors?
Direct peers on record are Bioplus Life Sciences, Synokem Pharmaceuticals, Akums Drugs & Pharmaceuticals, Zim Laboratories, Tirupati Medicare and Centaur Pharmaceuticals. Broad incumbents are Cipla, Mankind Pharma and Alkem Laboratories. Morepen Laboratories is listed as an emerging player.
Does Saar Biotech have an API?
No public API is recorded for Saar Biotech.
What industry is Saar Biotech in?
Saar Biotech's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 325412 and its SIC code is 2834.